Neurotrope, Inc. Common
NTRP
NTRP was delisted on the 1st of December, 2020.
31 hedge funds and large institutions have $2.03M invested in Neurotrope, Inc. Common in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.
8,700% more call options, than puts
Call options by funds: $88K | Put options by funds: $1K
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
17% more capital invested
Capital invested by funds: $1.75M → $2.03M (+$289K)
11% more funds holding
Funds holding: 28 → 31 (+3)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$287K |
| 2 |
OGC
One68 Global Capital
New York
|
+$128K |
| 3 |
MA
MYDA Advisors
Woodmere,
New York
|
+$96.3K |
| 4 |
Squarepoint
New York
|
+$63K |
| 5 |
Two Sigma Advisers
New York
|
+$61.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$701K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$61K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$22.6K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$11.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.49K |
NTRP Hedge Fund Activity: Q2 2020 in Review
31 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q2 2020, worth a combined $2.03M — up 17% from $1.75M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NTRP positions and 5 closed out — a net gain of 3 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $287K. The largest seller was Anson Funds Management, exiting entirely with an estimated $701K sold.
- 31 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q2 2020, up from 28 in Q1 2020.
- Funds reported $2.03M of Neurotrope, Inc. Common stock for Q2 2020, up 17% quarter-over-quarter.
- 8 funds opened new Neurotrope, Inc. Common positions in Q2 2020 and 5 closed out, a net change of +3 holders.
- The largest Neurotrope, Inc. Common buyer in Q2 2020 was Renaissance Technologies, an estimated $287K added.
- The largest Neurotrope, Inc. Common seller in Q2 2020 was Anson Funds Management, an estimated $701K sold.
Based on aggregated 13F filings for Q2 2020.